As of 2026-03-14, the Relative Valuation of SQZ Biotechnologies Co (SQZ) is (57.53) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.44 USD, the upside of SQZ Biotechnologies Co based on Relative Valuation is -13324.8%.
The range of the Relative Valuation is (51.03) - (60.46) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.9x - 23.8x | 21.1x |
| Forward P/E multiples | 18.1x - 22.4x | 21.6x |
| Fair Price | (51.03) - (60.46) | (57.53) |
| Upside | -11831.9% - -13999.9% | -13324.8% |
| Date | P/E |